MSD has called a halt to three trials of BTK inhibitor nemtabrutinib – added to its pipeline through its $2.7 billion ...
Donald Trump nominated Overton – a White House aide, physician, and vocal opponent of abortion – in the summer. The following ...
The UK government has said it will end the NHS's controversial contract with US tech firm Palantir, but not until 2029 – two ...
Berkeley Heights, NJ – April 15, 2026: Axtria Inc., a global leader in AI-first data analytics solutions for the life sciences industry, today announced the acquisition of Conexus Solutions, a premier ...
Real-World Evidence for the Impact of Company-Led Medical Education – Medscape Medical Affairs explores the question of ...
Eledon Pharmaceuticals has revealed that two patients with type 1 diabetes achieved a 'functional cure' after receiving a transplant of insulin-producing islet cells in combination with its ...
AstraZeneca's rare disease unit Alexion has won regulatory approval in the US and EU for Klygefa as a generalised myasthenia ...
Access and clarity should not be treated as separate problems. When organisations treat clarity as part of access, they ...
Novo has published the results of a clinical trial of its Wegovy injection in children aged six to 12 with obesity, showing ...
Helus Pharma has revealed data from a phase 3 trial of HLP003 that showed evidence of efficacy in major depressive disorder ...
The FDA has said it cannot approve Summit Therapeutics and Akeso's PD-1xVEGF inhibitor ivonescimab, delaying a drug that is ...
New Orleans hosted this year’s AAPS PharmSci 360 at the Ernest N. Morial Convention Center. For those fortunate enough to ...